Soy isoflavones in cancer: molecular pathways, pharmacokinetic constraints and translational opportunities.

Durmaz Kursun OE, Kalemoglu E, Sahin K, Kucuk O

Open source

DOI
10.1080/10408398.2026.2751399
Published
2026 Oct 23
Container
Critical reviews in food science and nutrition
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/10408398.2026.2751399,
  title = {Soy isoflavones in cancer: molecular pathways, pharmacokinetic constraints and translational opportunities.},
  author = {Durmaz Kursun OE and Kalemoglu E and Sahin K and Kucuk O},
  year = {2026},
  journal = {Critical reviews in food science and nutrition},
  doi = {10.1080/10408398.2026.2751399},
  url = {https://doi.org/10.1080/10408398.2026.2751399}
}

RIS

TY  - JOUR
TI  - Soy isoflavones in cancer: molecular pathways, pharmacokinetic constraints and translational opportunities.
AU  - Durmaz Kursun OE
AU  - Kalemoglu E
AU  - Sahin K
AU  - Kucuk O
PY  - 2026
JO  - Critical reviews in food science and nutrition
DO  - 10.1080/10408398.2026.2751399
UR  - https://doi.org/10.1080/10408398.2026.2751399
ER  - 

APA

OE, D. K., E, K., K, S., & O, K. (2026). Soy isoflavones in cancer: molecular pathways, pharmacokinetic constraints and translational opportunities.. Critical reviews in food science and nutrition. https://doi.org/10.1080/10408398.2026.2751399

Source records